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l.0. INTRODUCTION
uch has been learned about the best practices relative to
uidelines applied consistently at the bedside in the three
merican College of Cardiology Acute Myocardial Infarc-
ion Guidelines Applied in Practice (ACC AMI-GAP)
emonstration projects. The results and knowledge gleaned
rom these projects have been widely shared at national
onferences (1–6) and in peer-reviewed journals (7–10), and
ave diffused into local practices. In differentiating between
he spread of good practice through diffusion or dissemina-
ion, Sarah W. Fraser defines diffusion as a passive activity
hereas dissemination is a more planned and controlled
ctive process (11). Many local hospitals may have imple-
ented the ACC AMI-GAP tool kit either through
iffusion or dissemination, with success dependent on the
esistance met and the ability to recognize and overcome
arriers to success. Presented here is an organizational
ramework for spreading the successful practices learned
rom the AMI-GAP quality improvement (QI) demonstra-
ion project through dissemination, or a planned controlled
ctivity that will support successful project implementation.
hese recommendations are based on the three ACC
MI-GAP projects and what was learned about the impact
f using standardized tools and how to successfully imple-
ent an inpatient QI project, and the impact of creating a
tandardized care system for AMI.
Suggested reading:
. Eagle KA, Gallogly M, Mehta RH, et al. Taking the
national guideline for care of acute myocardial infarction
to the bedside: developing the Guidelines Applied in
Practice (GAP) initiative in southeast Michigan. Jt
Comm J Qual Improv 2002;28:5–19.
. Mehta RH, Montoye CK, Gallogly M, et al. Improving
the quality of care for acute myocardial infarction: the
Guidelines Applied in Practice (GAP) initiative. JAMA
2002;287:1269–76.
. Mehta RH, Montoye CK, Faul J, et al. Enhancing
quality of care for acute myocardial infarction: shifting
the focus of improvement from key indicators to process
of care and tool use: American College of Cardiology
AMI GAP project in Michigan: Flint and Saginaw
expansion. J Am Coll Cardiol 2004;43:2166–73.t
From the *St Joseph’s Mercy Hospital, Ann Arbor, Michigan; and the †University
f Michigan Cardiovascular Center, Ann Arbor, Michigan.. Montoye CK, Mehta RH, Baker PL, et al. A rapid-cycle
collaborative model to promote guidelines for acute myo-
cardial infarction. Jt Comm J Qual Saf 2003;29:468–78.
. Fraser SW. Accelerating the Spread of Good Practice:
A Toolkit for Health Care. United Kingdom: King-
sham Press, 2002:3–13.
.0. ACC AMI-GAP QI MODEL
he QI model for the ACC AMI-GAP projects has
volved from all three projects. The first project (pilot)
ecruited volunteer hospitals and required physician cham-
ions and project leaders at each hospital to lead the
rojects. Hospitals were provided data feedback to stimulate
I activities and the ACC AMI tool kit, which was to be
odified and implemented in their processes of care. The
ilot project also made available external physician/nurse
eams to provide one-on-one QI support and guidance. The
xternal team members were clinicians from the southeast
ichigan community. The second project (Flint-Saginaw
xpansion) provided one-on-one QI support via a consistent
xternal team with physician/nurse members from the
roject leadership group. Project leaders were also brought
ogether for several learning and sharing meetings at critical
hases in the project—monitoring tool use, remeasurement,
nd results phases.
Incorporating successes and lessons learned from the
AP pilot project (8,9) and the Flint-Saginaw Expansion
AP project (10), the third project, entitled the Southeast
ichigan Expansion GAP project, was launched in the Fall
f 2002. Like the first two GAP projects, this project aimed
o improve the care of patients with AMI through imple-
entation of the ACC AMI tool kit and a concentrated QI
ntervention led by local cardiology physician champions
nd hospital project leaders. The level of support provided
o hospital teams was intensified through implementation of
he ACC AMI-GAP collaborative model, which was based
n the lessons learned from the previous GAP projects (10).
he GAP collaborative model was modeled after that of the
nstitute for Healthcare Improvement (IHI) breakthrough
eries model (BTS) (12) with several important distinctions.
n both models, teams from multiple organizations come
ogether to work on a common problem. In the IHI model,
he teams work at their own pace, sharing successes and
essons learned at learning sessions held periodically
hroughout the time span of the collaborative. The ACC
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AMI ACC-GAP™ Case Study November 15, 2005:1B–29BMI-GAP collaborative model is a research model imbed-
ed in a QI model, in that all hospital teams are working
ithin the same time frame for baseline measurement,
ntervention implementation, and remeasurement. Further-
ore, the ACC AMI-GAP collaborative model is a collab-
rative rapid-cycle model that focuses on successful project
mplementation through five distinct QI phases: planning,
ool implementation, monitoring tool use, remeasurement,
nd results (Fig. 1).
These phases were designed to support successful project
mplementation and to focus hospital QI activities on the
se of the evidence-based AMI care tools. Successful tool
se is critical because, as demonstrated in previous projects,
hen the AMI specific tools are used (Fig. 2), rates for
uality of care measures are high (8,9), and there is a
orresponding improvement in 30-day and 1-year outcomes
Tables 1, 2, and 3) (13). Physician champions and project
eaders subsequently coordinated multidisciplinary teams to
lan their respective hospital’s activities. The multidisci-
linary teams developed a systematic process for implemen-
ation of their project, including an introductory kickoff of
rand rounds at each hospital. Five project leader learning
essions that corresponded with the phases of project
mplementation were conducted to:
igure 1. The American College of Cardiology Acute Myocardial Infarction G
ith a collaborative model for improvement with all participants implemen
Abbreviations and Acronyms
ACC AMI-GAP  American College of Cardiology
Acute Myocardial Infarction
Guidelines Applied in Practice
ACS  acute coronary syndrome
AHA  American Heart Association
AMI  acute myocardial infarction
BTS  breakthrough series model
CQI  collaborative quality improvement
IHI  Institute for Healthcare
Improvement
JCAHO  Joint Commission on Accreditation
of Healthcare Organizations
PCI  percutaneous coronary intervention
PDSA  plan-do-study-act
QI  quality improvementost-measurement occurring within the same time frame. Learning sessions focus on
hases of planning, tool implementation, monitoring tool use, remeasurement, andReview goals of the current phase
Identify barriers
Share successes and lessons learned and
Collectively develop strategies to overcome barriers and
to support progress
Monitoring the successful implementation of each project
hase and, more importantly, monitoring and increasing the
ate of tool use, was a critical component of the collaborative
odel and a major focus of each learning session. Described
ere are components of each phase, discussion of how to
mplement each phase, and measures of successful imple-
entation of each phase. This document reviews the five
hases of project implementation that were the focus of the
hird GAP project (Appendix A). Although these recom-
endations can be applied to any clinical topic, for both
npatient and outpatient setting QI projects, the examples
iven here are based on our experiences with the AMI-GAP
rojects.
Suggested reading:
. Montoye CK, Mehta RH, Baker PL, et al. A rapid-
cycle collaborative model to promote guidelines for
acute myocardial infarction. Jt Comm J Qual Saf 2003;
29:468–78.
. Eagle KA, Montoye CK, Riba AL, et al. Guideline-
based standardized care is associated with substantially
lower mortality in Medicare patients with acute myo-
cardial infarction. J Am Coll Cardiol 2005;46:1242–8.
.0. PLANNING PHASE
he planning phase of the project is perhaps the most
ntense both for the team and for the project leaders.
lanning for every aspect of the project needs to be
ompleted and incorporated into a written action plan.
fter establishing a team, the GAP tools need to be
odified to meet the needs of the local culture; goals and
im statements need to be written; monitoring and mea-
urement tools need to be designed; and the educational and
mplementation plans need to be developed. And all of this
lines Applied in Practice (ACC AMI-GAP) project merges a research model
he same intervention (ACC AMI-GAP tool kit) and aggregate pre- anduide
ting tincreasing the use of the GAP tools and successful implementation of project
results. The Breakthrough Series Collaborative Model © 2001 Institute (12).
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November 15, 2005:1B–29B AMI ACC-GAP™ Case Studyeeds to be documented in a written action plan and
imeline. Examples of a written action plan and a planning
hecklist are included in Appendix B. The written action
lan corresponds with the phases and steps of the AMI-
AP collaborative model, and the information included in
ection 3.4 in the following text of this manual. The
lanning checklist is used to double-check the team’s work
efore proceeding beyond the planning phase. While the
ocus on project phases is unique to the ACC AMI-GAP
ollaborative model, the basic QI principles and techniques
re not. These principles are the subject of numerous textbooks
nd articles, and have been the focus of numerous conferences.
everal references are listed here as suggested supplemental
eferences to this manual. The following section contains
etails about the planning phase and recommendations based
n the experiences of the three GAP projects.
Suggested readings:
. Langley GJ, Nolan KM, Nolan TW, Norman CL,
Provost LP. The Improvement Guide. San Francisco,
CA: Jossey-Bass Publishers, 1996.
igure 2. Adherence to early indicators in patients with and without eviden
n patients with and without the evidence of use of the standardized disch
able 1. Complications and Outcomes
omplications/Outcomes
Baseline (%) Post GAP (%)
p Valuen  1,368 n  1,489
n-hospital
Hypotension 419 (30.6) 492 (33.0) 0.17
Shock 16 (1.2) 18 (1.2) 0.92
Heart failure/pulmonary
edema
652 (47.7) 660 (44.3) 0.07
Stroke 68 (4.9) 78 (5.2) 0.74
Renal failure 340 (25.0) 357 (24.2) 0.61
Hemorrhage/bleeding 338 (24.7) 381 (25.6) 0.59
Transfusion 278 (20.3) 364 (24.4) 0.008
Discharge to acute care
hospital
174 (12.7) 162 (10.9) 0.13
In-hospital mortality 186 (13.6) 159 (10.4) 0.017
ater outcomes
30-day mortality 295 (21.6) 249 (16.7) 0.001
1-year mortality 524 (38.3) 494 (33.2) 0.004meprinted with permission from Eagle KA, et al. (13).. Institute for Healthcare Improvement. Available at:
www.IHI.org.
. Michigan Peer Review Organization Continuing Edu-
cation, Quality Improvement Education Program.
Available at: www.MPRO.org.
. Scholtes PR, Joiner BL, Streibel BJ. The Team Hand-
book. Madison, WI: Oriel Inc. Publishers, 2000.
.1. Identify a Focus
hich comes first, the team or the problem? Does a team
dentify a problem to solve or does a problem exist and a
eam forms to address it? Local situations will determine the
rder of events, but for the purposes of this manual, it is
ssumed that the readers have decided or are in the process
f deciding to implement an AMI-GAP project. This
ecision may be sparked by regulatory agencies, identifica-
ion of a high cost or high volume patient population, a
nown opportunity for improvement in quality of care
ndicators, and/or interest by local cardiologists or other
linicians from reading the articles that have reported the
uccesses of the ACC AMI-GAP projects. The care of
atients with AMI is very broad. As such, the ACC
MI-GAP projects and this manual have narrowed the
ocus to a QI initiative that supports health care providers in
aring for patients hospitalized with AMI, through the use
f standardized care tools that guide clinicians through
ecisions that are consistent with the ACC/American Heart
ssociation (AHA) guidelines.
.2. Project Support and Approval
efore proceeding with the AMI-GAP project, it is sug-
ested that hospital administration and leadership from
ardiology, nursing, emergency care, and QI declare the
roject a priority and provide support and resources. In all
hree previous GAP projects, teams that had this approval
nd support appeared to be more successful because person-
el resources and support for all phases of the project were
the use of standardized admission orders, and adherence to late indicators
form.ce ofade available. This supportive group is labeled differently
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AMI ACC-GAP™ Case Study November 15, 2005:1B–29By various sources as the “guidance team” or “team sponsor”
14), “system leaders” (15), “leadership team,” or simply
leaders” (16,17). They are commonly defined as those who
re in a leadership or management position, who have a
take in the process or problem (stakeholder), and have
ecision-making authority, clout, and, most importantly,
nancial and manpower resources to support the QI activity.
The list may be expanded beyond the list provided in the
revious text; it is important that each team identify from
hom they need support and be able to articulate the
nvolvement that is needed. The support and involvement
as obvious and visible in the teams that were most
uccessful in the three GAP projects. For example, the
ickoff grand round events were high-profile events with
articipation by executive leadership and presentations by
able 2. Independent Predictors of Mortality—Influence of GAP
In-Hospital Mortality 30-Day
Variable
Odds
Ratio 95% CI p Value Variable
Odds
Ratio
ge* 1.04 1.02–1.06 0.0001 Age* 1.044
o prior MI 0.69 0.51–0.94 0.019 Prior PCI 0.60
hest pain 0.41 0.31–0.55 0.0001 Chest pain 0.41
eart rate* 1.006 1.001–1.012 0.03 Heart rate* 1.005
nt. MI 1.55 1.16–2.01 0.003 Ant MI 1.499
nf. MI 1.84 1.37–2.48 0.0001 Inf. MI 1.31
trial fib 1.48 1.09–2.01 0.01 Atrial fib 1.38
CI 0.41 0.25–0.67 0.0003 Hct 30 1.41
ABG 0.53 0.28–0.99 0.05 LVEF 1.40
roponin1* 1.001 1.001–1.002 0.0002 PCI 0.34
AP 0.79 0.59–1.04 0.09 CABG 0.37
Troponin1* 1.001
GAP 0.74
-statistic  0.766 C-statistic  0.757
Continuous variable. Reprinted with permission from Eagle KA, et al. (13).
Ant  anterior; CABG  coronary artery bypass graft surgery; COPD  chronic
ct  hematocrit; HF  heart failure; Inf  inferior; LVEF  left ventricular ejec
able 3. Independent Predictors of Mortality—Influence of Stan
In-Hospital Mortality 30-D
Variable
Odds
Ratio 95% CI p Value Variable
Odd
Rat
ge* 1.04 1.02–1.06 0.0001 Age* 1.0
o prior MI 0.69 0.51–0.94 0.019 History of
stroke
1.7
hest pain 0.41 0.31–0.56 0.0001 History of
PCI
0.4
eart Rate* 1.006 1.001–1.012 0.03 Chest pain 0.4
nt. MI 1.55 1.16–2.07 0.003 LVEF 1.4
nf. MI 1.84 1.37–2.48 0.0001 PCI 0.2
CI 0.41 0.25–0.67 0.0004 CABG 0.1
ABG 0.53 0.28–0.99 0.05 Heart failure 0.5
roponin1* 1.001 1.001–1.002 0.0002 GAP 0.8
AP 0.81 0.59–1.13 0.21 Discharge
tool
0.5
tandard
Orders
0.92 0.63–1.35 0.68
-statistic  0.767 C-statistic  0.800Continuous variable. Reprinted with permission from Eagle KA, et al. (13).
Abbreviations as in Table 2.hysician champions from cardiology as well as the emer-
ency department. At some sites, the chief executive officer
ent letters to physicians announcing the project and the
xpectation that the standing orders would be used! Suc-
essful projects had resources for monitoring tool use rates,
nd team members were able to attend all of the learning
essions. The support and involvement of leaders was obvious
n successful teams and less so in those teams that seemed to
truggle at various phases of their project implementation.
.3. Creating a Team
ost often a team comes together for the life span of the
roject and to report the results to an oversight leadership
eam. Team size, structure, and membership may vary,
ccording to the organizational culture, but it is critical to
rtality 1-Year Mortality
5% CI p Value Variable
Odds
Ratio 95% CI p Value
03–1.06 0.0001 Age 1.05 1.04–1.07 0.0001
41–0.88 0.01 Prior HF 1.54 1.24–1.91 0.001
32–0.52 0.0001 Prior COPD 1.38 1.11–1.71 0.004
01–1.01 0.03 Chest pain 0.43 0.35–0.53 0.0001
17–1.91 0.001 Inf. MI 1.30 1.05–1.62 0.015
02–1.68 0.04 Atrial fib 1.29 1.02–1.62 0.03
07–1.79 0.015 Hct 30 1.75 1.32–2.31 0.0001
03–1.92 0.03 LVEF 1.49 1.21–1.83 0.0002
10–1.79 0.006 PCI 0.34 0.24–0.47 0.0001
22–0.52 0.0001 CABG 0.30 0.18–0.48 0.0001
21–0.66 0.0008 Troponin1* 1.001 1.000–1.002 0.002
01–1.002 0.0001 GAP 0.78 0.64–0.95 0.013
59–0.94 0.012
C-statistic  0.767
uctive pulmonary disease; fib  fibrillation; GAP  Guidelines Applied in Practice;
raction; MI  myocardial infarction; PCI  percutaneous coronary intervention.
Care Tools and GAP
rtality 1-Year Mortality
95% CI p Value Variable
Odds
Ratio 95% CI p Value
.02–1.06 0.0004 Age 1.05 1.03–1.06 0.0001
.23–2.50 0.002 Prior HF 1.61 1.26–2.05 0.0001
.32–0.52 0.0001 Prior COPD 1.55 1.22–1.98 0.0004
.33–0.66 0.0001 Chest pain 0.51 0.40–0.65 0.0001
.10–1.79 0.006 Anemia 1.74 1.27–2.37 0.0005
.09–0.54 0.001 LVEF 1.46 1.16–1.85 0.0014
.03–0.62 0.009 PCI 0.34 0.23–0.51 0.0001
.39–0.91 0.017 CABG 0.22 0.12–0.42 0.0001
.59–1.20 0.339 GAP 0.95 0.75–1.21 0.687
.27–0.98 0.042 Discharge
tool
0.53 0.36–0.76 0.0006
C-statistic  0.774Mo
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November 15, 2005:1B–29B AMI ACC-GAP™ Case Studyuccess that the team is comprised of members that meet the
eeds of the project. Those teams most successful in the
CC AMI-GAP projects were led by very active and
edicated physician champions and project leaders. The
ulture of the facility will determine how the project leaders
re selected; they may volunteer, it may be assumed that a
ardiology nurse specialist and chief of cardiology assume
he role, or it may be a QI specialist and cardiologist who are
nterested in QI. Successful teams also had team members
hat were representative of the entire process of caring for
atients with AMI, such as representatives from the emer-
ency department, critical care, cardiac catheterization lab-
ratory, and post-critical care nursing units. Additionally,
embers representing the work that needed to be done to
mplement and measure the QI effort should be included on
he team, such as QI specialist, data collectors, medical
ecords, and clerical staff. A sample team member list is
rovided in Appendix B.
The ACC AMI-GAP collaborative model provides a
oadmap for the team leadership to follow as they guide the
eam and caregivers through a successful project implemen-
ation, but it is important that all team members accept
esponsibility and accountability for the work necessary for
successful journey.
.3a. Physician Champion Role. There is often confu-
ion regarding the physician champion role with some
nterpreting the role as comparable to the role of an opinion
eader. An opinion leader is one who is often the first to
now about and adopt innovations, one whom their peers
ook to for guidance or opinion, and one who can informally
nfluence others’ attitudes or behavior (18).
The physician champion may very well be an opinion
eader, but rather than simply exerting an informal influ-
nce, they need to be an operational leader in designing,
mplementing, and measuring improvement. The physician
hampion role was critical to the success of the GAP
rojects. Having the GAP standardized tools available was
ot enough to create change. Sites that had effective clinical
eadership provided by physicians and nurse leaders are
enerally more successful in achieving behavioral change or
ool use (19). The physician champion ideally is someone
ho is respected for leadership skills, clinical role-modeling,
nd practice outcomes, and is enthusiastic about achieving
igh-quality performance indicators and process improve-
ent. In the three GAP projects, they were most often a
ardiologist, but if the majority of patients with AMI are
reated by a different specialist group, such as family practice
r internal medicine for example, then the physician cham-
ion may be from that physician group. Another model is to
ave the project led by both a cardiologist and a non-
pecialist, complementing each other. In the third GAP
roject, the group of hospitals that was the highest achievers
f tool use and QI rates was led by physician champions
rom both the cardiology and the emergency department.
Overall responsibilities for the physician champions are
oted in the following list. The level of involvement aoversight or day-to-day management) and the time spent
n these responsibilities depend both on needs of the project
nd of course availability. In general, the physician cham-
ion(s) should either lead efforts to or:
Provide clinical direction and support, oversight, and
coordination
Ensure academic detailing of evidenced-based therapy
(in care tools, presentations, and discussions)
Actively participate in project meetings
Be a clinical consultant and liaison, troubleshooter, and
resource for problem solving
Provide credibility with the medical staff: advocate pur-
poses, goals, and commitment to the project
Partner with project leader(s) to:
Œ Develop, customize, adapt, and implement the tools
Œ Develop action plans for implementing systematic
processes of care
Œ Help troubleshoot barriers to implementation, by first
identifying barriers and then facilitating strategies to
overcome barriers
Œ Monitor tool use and barriers to use in order to
optimize care
Œ Monitor progress of project
Œ Report project progress
The physician champion(s) is crucial to the success of the
roject. It was evident in all three GAP projects that when
he physician champion was not actively leading the project,
rand rounds were poorly attended, there was little, if any,
eedback to physicians who did not use the forms, project
eaders were frustrated with the lack of a partnership
mplementation, and tool use rates were less than the
ggregate mean. Those sites with high rates of tool use had
ery active and enthusiastic physician leadership, which was
ommitted to implementation and active, iterative change
equired to overcome barriers.
.3b. Project Leader Role. A variety of skills are required to
e an effective project leader. The project leader is the day-to-
ay project manager who ensures that the project is planned,
ctions are completed, reports are generated and reviewed, and
odifications to the plan are made. The project leader should
e someone who has a good understanding of QI principles
nd techniques and a basic knowledge of the process of caring
or patients with AMI. The project leaders in the three GAP
rojects were nurses, with the exception of two teams that were
ed very successfully by physician QI directors. The main
esponsibilities for the project leader are to ensure that a
omplete and detailed plan is developed, written, and success-
ully implemented, that project progress is monitored, and that
arriers to success are identified and strategies developed to
vercome them. An effective project leader is organized,
etail-oriented, able to lead meetings, and willing to delegate
hile providing expectations and guidance. The project leader
enerally is the individual who communicates to the rest of the
rganization, such as reporting to administration or presenting
t department or staff meetings. It is imperative that the project
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AMI ACC-GAP™ Case Study November 15, 2005:1B–29Beader develop a close working relationship with the physician
hampion and also have access to the physician champion
hen the need arises.
The project leader role is summarized as follows:
Day-to-day leader of team and project
Partner with physician champion to lead project
Convene team members and regularly scheduled meetings
Œ Prepare and provide agendas that include topics of
discussion, a time limit, and lead person for each topic
Œ Maintain a written record of each meeting
Œ Ensure meeting roles of leader, facilitator, timekeeper,
note keeper, and team member are maintained
Œ Provide team members with project explanation, ex-
pectations, and guidance for successful team meetings
and project implementation
Œ Utilize collaborative quality improvement (CQI) tools
when their use will facilitate effective discussion and
decision making
Lead team efforts to:
Œ Develop and implement action plans
Œ Monitor project implementation and use of tools
Œ Identify barriers to successful project implementation
and develop strategies to overcome them
Œ Report project progress
There can be no project without the project leader! The
ist looks short, but each item can be very complicated.
ffective project leaders have a unique combination of basic
linical and QI knowledge. The project leader does not have
o do everything in isolation, but needs to ensure that
verything has been done. In fact, in our three GAP
rojects, those leaders with detailed and comprehensive
ritten action plans and team members that were able to
hare the work load were more successful with project
mplementation. The project leader responsibilities may
equire 8 to 20 h per week depending on the team structure,
haring of responsibilities, and other positions already in
lace at the hospital, such as QI specialist, marketers, and
ata collectors.
.3c. Team Members and Structure. It may be obvious
ut needs to be acknowledged that those who have made the
ecision to implement an AMI GAP project cannot con-
uct the project in isolation or without the knowledge and
upport of others who represent care for AMI patients! It is
mportant to create a team structure that supports project
mplementation and team membership representing all
nits and staff that care for patients with AMI. It is
hallenging to spontaneously generate a list of stakeholders,
o creating a “high-level” process flow chart of AMI care
ill be useful. A “high-level” flow chart is generally 6 to 12
teps that show the major components of a process and,
herefore, may be helpful in understanding the process flow,
dentifying stakeholders, collecting data, and identifying
esources (20). When flow charting the care of the AMI
atient, it is important to start pre-hospital, through the
mergency department, catheterization laboratory, and rhrough critical care, general nursing units, and through to
ischarge. The flow chart should list all of the departments
hat care for the patient or influence the care of the patient
r project, laboratory services, radiology, pharmacy, pastoral
are, clerical staff, admitting staff, discharge planners, clin-
cal nurse specialist (CNS) or advanced nurse practitioner
ANP), information technology, medical records, QI de-
artment, cardiology services, executive or administration,
nternist, family practice, resource pools, and hospitalists.
reation of a stakeholders’ list following the flow chart is
elpful. The stakeholders’ list is not the same as the team
embers’ list. But the team members’ list can be generated
rom the stakeholders’ list. Creating the team members’ list
s described in the following text.
Some of the stakeholders may serve in an ad-hoc capacity,
r information-sharing capacity, but it is important to start
ith a full and complete list so that one can use all of the
esources and influences necessary for a successful project
mplementation.
Some teams may choose to conduct all of the business in
large group. Others may have smaller working group
eetings, with one member of the working group meeting
eporting to the larger group. It really is a matter of
reference and culture.
Being creative with team membership is easier when one
evelops a flow chart incorporating aspects of the project
nd measurement. Creative team structures observed in
revious GAP projects have included subgroups to work on
ool development and approval processing, data collection
nd reporting, educational planning and implementation,
mergency department implementation, processes and
imeliness of reperfusion, and oversight leadership groups.
or example, several teams recruited a marketer to help
evelop an educational and publicity plan. The marketer
as an ad-hoc member attending smaller planning meet-
ngs, and reporting to the larger group. Others enlisted a
epresentative from medical records to help plan sampling
or monitoring tool use and remeasurement. This was a key
erson to have input from when developing strategies to
vercome incomplete records at time of remeasurement.
any teams recruited clinical care unit champions who had
eparate meetings to report the successes and barriers of
heir respective units. Some may not realize the importance
f having an emergency medical services representative as an
d-hoc member. But the measurement of the early admin-
stration of aspirin quality indicator can be greatly influ-
nced by the documentation on the “run sheet,” which
ocuments care provided at home or during transport,
hich is often the time the aspirin is administered.
Different teams will need to meet at different intervals
nd at different times in the project depending on local
ircumstances. If the group decides to use the subteam
oncept, then each subteam should report to the larger
versight or leadership team. Team members need to be
esponsible for guaranteeing their attendance at meetings,
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f project implementation.
.4. Project Goals
fter collecting baseline data and information, it is impor-
ant to develop a clear and concise statement of the intended
mprovement for both the AMI quality indicators and for
are tool use. Further discussion about clinical tool use and
ndicator measurement is provided in sections 3.8 and 3.9 in
he following text. Comparing the baseline with the tar-
eted rates helps illustrate the rationale and importance of
he project.
Developing a specific aim statement for an AMI-GAP
roject should include specific targets for each of the quality
ndicators. It is useful to keep in mind that quality indicators
re NOT the guidelines; rather they help determine how
uccessfully we are applying the guidelines. The quality
ndicators that have been measured in the AMI-GAP
rojects are consistent with those that are measured by
enters for Medicare and Medicaid Services (CMS) and
oint Commission on Accreditation of Healthcare Organi-
ations (JCAHO) core measures. These include:
Early treatment indicators
Œ Aspirin 24 h before or within arrival
Œ Beta-blocker within 24 h of arrival
Œ Timely reperfusion;30 min for thrombolytics or90
min for percutaneous coronary intervention (PCI)
Later treatment indicators
Œ Aspirin prescribed at discharge
Œ Beta-blocker prescribed at discharge
Œ Angiotensin-converting enzyme inhibitors prescribed
for those with ejection fraction 40
Œ Smoking counseling
Test measures
Œ Measuring low-density lipoprotein cholesterol
Œ Prescription of low-density lipoprotein cholesterol-
lowering medication for those with elevated low-
density lipoprotein cholesterol
Œ Dietary counseling
Œ A hospital team may want to add additional indicators
such as referral to cardiac rehabilitation, use of emer-
gency department protocol, or documented education
regarding when and how to use nitroglycerin, or when
to prescribe additional pharmacologic agents such as
clopidogrel
Treatment indications should be reviewed and updated
whenever the guidelines and their corresponding perfor-
mance measures are updated
It is equally important for teams to identify an aim
tatement and target rate for tool use for all of the tools that
ill impact the quality indicator rates and that will be part
f the permanent record such as standing orders, discharge
ocument, and clinical pathway. Each of the three previous
MI-GAP projects showed that when the standardizeduideline-based care tools are used, the indicator rates are
igher and the documentation is more complete. The rate at
hich the tools are used is a good marker of how success-
ully the new process of care (using standardized forms) is
mplemented.
If hospitals have already been using standing orders, it is
seful to identify the baseline tool use rates and look for
rends of use. Identifying patterns of use allows the team to
rite an aim statement specific to the current status. For
xample, one team in the third GAP project found that the
tanding orders were not being used by the hospitalists. This
ed to development of a special focus in their plan with a
pecific aim statement related to use by hospitalists. Another
roup of hospitals assumed that their standing orders were
eing used and did not develop plans to increase their use.
he early treatment indicators did not improve because the
tanding order tool use had not changed.
Aim statements should be specific, measurable, and
hould include a target goal and a time frame. Teams may
evelop an overall aim statement for all of the quality
ndicators or a separate aim statement for each of the quality
ndicators. If they have high rates on some of the quality
ndicators, and an individual aim statement may not be
eeded for all indicators. Tool use aim statements may
ncorporate all of the care tools, or the team may select to
ave a separate aim statement for each care tool use. There
s an advantage to having separate aim statements for all of
he indicators and care tools. Different groups of caregivers
ay impact the rates or tool use, such as physicians
mpacting standard tool use rates and early indicators
ocumentation and nurses impacting the discharge tool use.
easuring these separately provides more information and
ata for feedback than if they were lumped together.
A word of caution is needed regarding aim statements.
ome teams have a tendency to be very cautious and will
rite aim statements reflecting only small incremental
mprovement. For example, a team wrote that the tool use
ill increase by 10% every month. It would take nine
onths to get to 90% if you are starting out at 0%! It would
e better to expect larger increments such as an increase of
5% each month or shorten the time frame to 10% every
eek or two weeks. Expecting a more substantial gain can
acilitate a departure from a practice-as-usual mindset to a
ystems-based concept.
Examples of clear, concise aim statements for an AMI-
AP project may be:
Increase rate at which beta-blocker is given to ideal
patients to 90% within six months
Smoking cessation counseling will be documented at the
rate of 90% within six months
AMI-specific discharge tools will be used consistently for
all patients discharged with diagnosis of AMI at a rate of
95% within six months
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he purpose of the action plan is to document a detailed
lan for implementing the AMI-GAP project. It is a
ritten, detailed plan including assessment of the current
tatus or resources related to AMI care, actions or strategies
hat will be implemented, persons responsible for activities,
ime frames, and measure of successful completion of the
arious phases of project implementation.
The action plan is best developed through a team effort.
sample action plan form is included in Appendix B, and
t provides a basic listing of issues to be planned for. Project
lans need to be individualized. The project leader and
hysician champion may want to provide a draft template
or the first project team meeting. This will help give
uidance to the team and provide structure for their discus-
ions.
Topics to be planned for include:
Team leadership members, structure, and meetings
Goals and aims statements
ACC AMI-GAP tool kit modification and printing
schedule
New (or revised) tool implementation or new systematic
process of care plan
Educational plan
Monitoring tool use
Remeasurement
Results
Reporting
 Project status
 Progress and results
Project implementation successes and barriers, and
results
.6. ACC AMI-GAP Tool Kit
he decision to implement the GAP project implies that
he ACC AMI-GAP tool kit will be used and that during
roject planning, hospital-specific tools will need to be
reated or existing tools modified to be consistent with the
CC AMI-GAP tool kit (21). At the very least, in order to
chieve the high rates reported for the quality indicators in
revious GAP projects, a standing order set and AMI-
pecific discharge document is needed. The ACC AMI-
AP template documents are included in Appendix C.
The hypothesis of the ACC AMI-GAP projects is that
he quality of AMI care can be enhanced through a
erformance improvement initiative that includes providing
nstitutions, caregivers, and patients with tools and strate-
ies, that targets treatment goals, focuses on improving key
rocesses of care, and optimizes adherence to guidelines.
uring the first GAP pilot project, core team members
onsisting of local cardiologists and nurses created templates
or the standardized forms that were to be used by each
ospital team. The templates were based upon the national
CC/AHA guidelines for AMI and tools that had already
een utilized successfully at several southeast Michigan cospitals (8). The templates were reviewed by the ACC’s
ask force on practice guidelines and GAP steering com-
ittee to confirm that they conformed to the national AMI
uidelines and after approval became the ACC AMI-GAP
ool kit. The GAP tool kit consists of seven critical pieces:
) AMI standard orders: for physicians to use to order
evidenced-based therapy or document contraindications
to their use;
) Clinical pathway: for nurses to use to follow the patient
through the expected course of treatment;
) Pocket guide/pocket card: an easy-to-use condensed
version of the guidelines for clinicians to carry in their
pockets;
) Patient information form: intended to be read by the
patient and family members that will help explain the
normal course of care and what they can expect during
their admission;
) Patient discharge form: to be used by the discharging
caregiver, usually a nurse, and the patient. This docu-
ment includes instructions about or contraindications to
the evidenced-based therapy, smoking, and dietary
counseling, follow-up appointments, and so on;
) Chart stickers: to remind the staff that the AMI-GAP
protocol should be followed; and
) Hospital performance charts: providing comparisons at
baseline and remeasurement for the quality indicators
and tool use rates.
The pocket guide/pocket card was created by the ACC/
HA Task Force for Practice Guidelines from the AMI
uidelines. Chart stickers were created by ACC project staff
o serve as a reminder to caregivers to provide appropriate
nd timely AMI-specific care to the patients.
The physician and nurse leaders and the multidisciplinary
eam at each hospital were expected to customize and
mplement the ACC AMI tool kit. Each of the three GAP
rojects provided different experiences with the tool kit. In
he pilot project, all sites utilized a standardized order set
nd discharge document, modifying their own to be con-
istent with the template or creating a new order set based
n the template. All order sets in the pilot project were
AMI order sets.” Most but not all hospitals used a critical
athway and the pocket guide and card. All had patient
ducational materials. None of the 10 selected to use the
hart stickers.
The experience with the five hospitals in the second
roject (Flint-Saginaw expansion) was different. All five
sed all pieces of the tool kit, again modifying their own
orms or creating new forms based on the templates. Several
f the hospitals chose to implement “acute coronary syn-
rome (ACS) order sets” rather than AMI-specific orders.
ome teams felt that an ACS order set was more inclusive,
nd help to ensure guideline-based care in patients with
CS in which the distinction between instable angina and
on–ST-segment elevation myocardial infarction was not
lear at admission. Hospital teams in the third GAP project
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November 15, 2005:1B–29B AMI ACC-GAP™ Case Studysed all of the tools, again with some creating ACS order
ets to capture more patients up front. Some sites reported
hat quality indicator rates were lower than expected because
he patients that presented without an obvious AMI were
ot started on the standing orders for AMI. Creating a
tandard order set that reaches all ACS patients allowed
hese institutions to capture those patients who eventually
ruled-in” with AMI.
Several hospitals were very creative with the patient
nformation form, incorporating the material into a profes-
ionally designed tri-fold brochure. Others incorporated
xplanations of commonly administered tests and proce-
ures such as electrocardiograms, telemetry monitoring,
chocardiography testing, and stress testing. Some sites
etermined that if the family was present in the emergency
epartment, the materials should be distributed to them at
he time of admission. Again, a given hospital’s culture and
re-existing care and education tools will dictate the final
esign for each project.
It is important to recall that new care forms may require
pproval of the “forms committee” thought by some to be
he most powerful committee in the hospital system! The
eview and approval process can sometimes be lengthy. The
eam should be aware of the process in advance including
he committee’s meeting schedule and a likely date when the
roject’s forms will be reviewed in order to create a realistic
ime frame for the action plan. Some hospitals may require
pproval from other pertinent committees such as cardiol-
gy and nursing practice in advance of the forms committee.
etting their feedback during the form development will
elp gain their approval for the finalized forms. Sometimes
he physician champion can favorably influence the time
equired by the forms committee. Teams need also to be
ensitive about the time required to typeset and print the
ew forms. This too can be a lengthy and time-consuming
ask. It would be detrimental to a project’s success to have to
elay an announced start date because the care forms had
ot been approved and were therefore not available.
.7. Planning for Implementation Phase
he implementation phase includes the educational plan
nd marketing plan execution and the implementation of
ew or modified GAP tools. The team must also plan a
ethod to evaluate the implementation phase and, very
mportantly, modify or create new plans and activities if
ecessary to achieve a successful implementation phase.
.7a. Educational Plan. One of the barriers to tool use
dentified during the first two GAP projects was that some
taff reported “I did not know anything about the GAP
roject.” The cause of this lack of knowledge could have
een that the project team didn’t plan educational presen-
ations to reach all of the staff, or that all of the staff did not
ttend the planned presentations. The important lesson
earned from the three GAP projects is that it is important
o develop an educational plan detailing the content for staff
ducation and scheduling educational events to reach all of whe staff. The measures of success for this aspect of the
roject are that the presentations are planned to be inclusive
f all staff that will be working with the care tools and that
n attendance record has been kept and evaluated for
ompleteness. Additional presentations can be planned to
nsure that all staff members are reached.
The following list is the recommended content for the
AP presentations:
Introduction of the team leadership and membership
Current status of AMI care and baseline quality indicator
rates
Introduction of the goals
Overview and results of the ACC AMI-GAP projects
Description of the hospital project, tools, process, eval-
uation, timeline
Expectations for staff participation
Consider planning the required number of educational
vents that will reach close to 100% of the following care
roviders and staff:
Physicians—cardiologist, internists, family practice, hos-
pitals, emergency
Nursing staff—emergency, critical care, general cardiac
units, discharge coordinators, advance practice nurses
Cardiopulmonary services
Clerical staff
Medical records department staff
Pharmacy department staff
Clinical laboratory staff
eview the process flow chart to determine that all pertinent
taff members that need to be reached with the educational
lan are involved
.7b. Project Kickoff Educational Event. The method-
logy of all three GAP projects included a project kickoff
vent held at each hospital. This educational event was a
resentation by the project and hospital leadership and
ncluded an overview of the GAP project and previous
ndings and specifics regarding the hospital’s project forms,
imeline, and expectations. The main objective was to create
n awareness of the project, promote participation by all
taff, and reach a target audience of physicians—
ardiologists, internists, family practice, and all others who
are for patients with AMI. The event typically was a
resentation at a normally scheduled or specially convened
hysician meeting with additional staff invited to the “ACC
MI-GAP Kickoff.” In the three GAP projects, we found
hat using an already existing meeting was the best forum to
aximize attendance. Having the nationally visible and
ocal cardiologists as guest speakers, and advertising their
resentations, was a drawing card for physician attendance.
any hospital teams created a very enthusiastic event thatas well marketed, and with upbeat promotions from the
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AMI ACC-GAP™ Case Study November 15, 2005:1B–29Bhief executive officers or institutional leaders as well as
resentations from emergency medicine and cardiology
hysician champions and project leaders.
Participation in a multihospital collaborative project such
s the ACC AMI-GAP collaborative is not required to have
successful project kickoff. Any hospital project can be
icked off in this manner. Featuring a prominent local
xpert as a guest speaker can serve as a drawing card for the
arget audience, and the project leaders can use the event to
each a large number of people with one event.
.7c. Implementation of New Care Tools. Many QI
pecialists recommend that changes be tested on a small
cale before spreading to a larger scale (17,20). This is an
ffective strategy for many problems, but may be less than
deal for certain aspects of the GAP initiative. If, for
xample, the team decided to use the new tools on only
elect units, there would be inconsistent use of standard
rders between units, thus contradicting the term “standard
rder” and causing confusion about using them. This is
specially true if teams were to design a project that
verlapped the use of old and newly modified standing
rders. It is recommended that teams select a start date on
hich all staff on all units will start using the new tools.
eams will need to develop plans for removal of old forms,
lacement of new forms, and follow-up to determine that
he new care tools are being used. If the team has unit
hampions, they often can accept accountability for this part
f the project. Then, having unit managers and clerical
upport staff assume responsibility for ensuring the avail-
bility of tools is important.
The process by which the care tools are made available to
he physicians and nurses needs to be determined. Do the
mergency department physicians start the standing orders?
hat decision is very dependent on the usual practices at
ach site. Will the discharge orders be placed with the
urses notes, or will the nurse have to go hunting for the
ew special AMI form? Will the nurse be required to
omplete the general discharge form as well as the new AMI
ischarge form? These last two questions are examples of
ssues that should be defined before the project begins. Both
f these, care forms not on the charts and requiring two
eparate discharge forms, were considered barriers to tool
se in previous GAP projects and should be taken into
onsideration when planning tool implementation.
An important component of the implementation plan is
he start date for use of the new tools. This should be part
f the plan and announced during the educational events.
aution should be used to avoid dates that conflict with
ther important events in the hospital, holidays, high
acation periods, and so on.
.8. Planning for Monitoring Tool Use Phase
onitoring clinical care tool use is critical because the tool
se rate is a determination of project success. During the
lanning for this phase, the team will need to create a
echanism to monitor use of the care tools, develop a bampling strategy, determine who will collect the data, and
t what intervals. Frequent monitoring, such as every two
eeks, should occur in the first few months of a project,
ntil the team is confident that the majority of barriers have
een identified. The plan should allow the team to answer
he following questions:
At what rate are the care tools being used?
What are the barriers to tool use?
What are the successes to tool use?
Are there patterns of high rates?
Are there patterns of resistance?
Are there successes in one unit that can be applied to
units where there is resistance?
What changes are needed to increase tool use?
This concept was first tested in the second GAP project
nd became an expectation in the third project. Teams that
onitored tool use were best able to increase the clinical
are tool use as the project progressed.
The first challenge is to determine how to identify a
ample of records to monitor. Some teams had the clinical
aboratories generate a daily or weekly list of patients with
levated serum troponin levels and then this list was used to
reate a sample of charts for review. Other teams used unit
hampions to track cases and review charts for tool use.
ome teams asked the hospital chart coders to check for tool
se, and others asked the clerical staff to keep a list at
ischarge. A few teams with more resources reviewed all
ecords concurrently and provided individual feedback to
hysicians and nurses regarding the use of standard orders
nd discharge documents.
The monitoring tool can be as simple as a checklist that
ncludes the following information:
Patient identifier
Standard order
Discharge documents
Critical pathway
Patient education
Other
The leadership team also needs to create a forum for
eceiving feedback from the staff. The most valuable infor-
ation is to determine why or why not the tools are being
sed. Feedback can be solicited one-on-one or in groups
uch as staff meetings. Quality improvement strategies that
equire active participation are often very useful, including
rainstorming, identifying restraining forces to tool use, or
pen dialogue, to name a few (20). Team members who are
omfortable leading discussions with staff and with whom
he staff are relaxed and open are good facilitators for this
ery important task. Thoughtful planning in advance to
elect a method for soliciting feedback will allow the team
ember to be well organized and rehearsed before conduct-
ng the feedback meetings. Discussion about overcoming
arriers in this phase is discussed in section 4.0.
3S
m
t
t
A
p
m
G
l
a
I
l
s
n
d
t
c
o
i
s
t
m
c
t
e
p
m
n
w
m
p
a
g
d
p
b
m
i
c
d
t
c
n
t
a
h
b
m
i
c
m
v
f
a
o
i
a
m
s
t
t
i
b
i
s
m
p
3
T
c
O
d
t
D
c
Œ
Œ
Œ
Œ
c
m
e
f
c
s
w
p
p
a
h
p
p
3
A
s
h
p
o
l
11BJACC Vol. 46, No. 10 Suppl B Montoye and Eagle
November 15, 2005:1B–29B AMI ACC-GAP™ Case Study.9. Planning for Remeasurement Phase
everal aspects of the project need to be measured. The
ost obvious are measures of processes of care reflected in
he rates of performance of the quality indicators such as
hose listed in section 3.4. Most hospitals implementing the
MI-GAP project have identified this clinical topic as a
riority area and may be collecting and submitting the core
easures for AMI care to the JCAHO. In the previous
AP projects, there have been occasions when project
eaders were not aware of how AMI cases were identified
nd/or how the data were collected or rates calculated.
ncluding someone from the “core measures process” on the
eadership team provides valuable local insight to the mea-
urements of the quality indicators. Those teams who are
ot collecting data via the core measures tools will need to
evelop an abstraction tool that defines the patient popula-
ion, defines exclusion and inclusion criteria for each indi-
ator, and collects the variables that allow for measurement
f the criteria, and then determine an analysis plan. Defin-
ng the components of the data collection is beyond the
cope of this manual. However, a good source of informa-
ion for such an activity can be found under performance
easures on the JCAHO website (22).
Many leadership teams want to measure aspects of the
are process that go beyond the quality indicators, such as
he care provided to those patients transferred from other
mergency departments or acute care centers. This group of
atients, by definition, is eliminated from the early treat-
ent indicator measures in the core measures, and would
ot be measured in the core measures report. The team thus
ill have to develop an additional strategy to collect infor-
ation on those transferred to their site. In another exam-
le, some teams will want to measure timely reperfusion for
ll patients, including those coming directly to the emer-
ency department and those transferred from others. This
istinction is obviously important because the flow for the
atients is different and the actions to increase guideline-
ased care will also be somewhat different.
There may be other indicators that the team wants to
easure, such as referral to cardiac rehabilitation, or the test
ndicators of measuring and treating cholesterol, or dietary
ounseling. Leadership teams might be interested in the
ocumentation of contraindications to the recommended
reatments with aspirin, beta-blockers, angiotensin-
onverting enzyme inhibitors, or reperfusion. These may
ot be captured with the core measures abstraction tool, so
he team will have to define how these variables will be
bstracted and rates calculated.
As previously mentioned, the initial GAP experiences
ave shown the importance of monitoring tool use rates
oth during a baseline period and during the remeasure-
ent phase. In all three GAP projects, there was a signif-
cant increase in the quality indicator rates when the clinical
are tools were consistently used. Some leadership teams
ay wish to identify the rate of clinical tool use among sarious types of physician groups such as cardiologists,
amily practitioners, and internists. If the measurement plan
nd abstraction mechanism does not include measurement
f care tool use, such observations are not possible. An
mportant exercise that the team must consider is to develop
grid that lists the variables being collected and cross
atches these with the quality indicators and other mea-
ures used to evaluate the project.
Remeasurement may be predetermined or may occur after
he tool use rates are at or near the goal established by the
eam. If the remeasurement time period is predetermined, it
s best to allow a several-month period for the new tools to
ecome part of the systematic process of care. If the quality
ndicators are being measured as part of the core measures
ubmission to the JCAHO, the remeasurement time period
ay coincide with one of the routine quarterly measurement
eriods.
.10. Planning for the Results Phase
his phase is meant not only to analyze the data that were
ollected, but also to determine successes and next steps.
versight teams should collectively review the analysis and
raw conclusions about the status of the project relative to
he targets that were established in the planning phase.
ecisions and recommendations about new processes or
hanges implemented for the project could include:
Adopt the change;
Abandon the change; or
Alter and continue cycles of improvement;
Continue until target is reached.
Or perhaps the desired state has been achieved, in which
ase the team needs to make plans for sustaining improve-
ent and monitoring the care tool use and indicator rates to
nsure the improvements are sustained.
During the results phase it is important to provide
eedback to all of the involved staff and departments. This
an be done with presentations at departmental meetings or
taff meetings, but planning in advance for these activities
ill help them with budgeting and scheduling. Some
revious GAP participants have used newsletters, reports in
ay checks, and poster story boards. Certainly this should be
time to celebrate the successes and acknowledge those who
ave the supported the project! A strategy used by one
revious GAP team was to have the marketing department
lan a special event for sharing the results.
.11. Measures of Successful Planning
t the conclusion of this phase of the project, team leaders
hould create and review a checklist to determine if they
ave planned for all aspects of the project. An example of a
lanning checklist is included in Appendix B, but each
versight team should create their own unique and inclusive
ist to capture all of their planning needs. Measures of
uccessful planning include:
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Project leader identified
Team members and team structure finalized
Meeting schedule determined
Forms modified or created
Œ Standing orders
Œ Discharge document
Œ Critical pathway
Œ Patient information form
Œ Back from printer
QIs selected and QI calculation plan determined
Data collection methodology determined
Plan and tool for monitoring care tool use designed
Baseline data collected and reviewed; aim statement
written
Tool implementation start date determined
Kickoff scheduled
Educational plans written and sessions scheduled
“Learning sessions” planned
Evaluation plan written
Reporting plans determined, report format designed
Project plan written
.12. Potential Barriers in Planning Phase
umerous barriers may surface during the planning phase.
he best defense is to be very well organized and detailed in
he planning phase, stay alert to barriers, and strategize to
vercome the barriers. Being alert to prevent the occurrence
f the following barriers that were identified in previous
AP projects will help prevent problems (Table 4).
.0. IMPLEMENTATION PHASE
f a project is thought of as one big implementation phase,
eaders and team members can feel very overwhelmed.
reaking the project into phases including planning, imple-
entation, monitoring, remeasurement, and result, helps
arrow the focus. Success in one phase will support success
able 4. Barriers of Planning Phase
Barriers During Planning Phase Strategies to Overcome Barriers
. Project leaders may: 1. Organize approach to project
Feel overwhelmed
Have competing priorities
● Prepare a detailed checklist
with time line
● Reference the GAP
implementation manual
. Project leaders may: 2. Obtain support
Lack necessary Q1 skills, and
comfort level to lead the project
Anticipate a lack of support
● List help needed, and potential
supporters
● Include these “supporters” as ad
hoc team members
● Recruit unit champions
● Define physician champion role
. Medical Forms Committee 3. Forms approval process
Lengthy approval process
Slow process may jeopardize
start date
● Physician champion to facilitate
approval
● Approval may be more rapid ifadefined as “pilot”n the subsequent phase. This is particularly true of the
mplementation phase. A successful and thorough planning
hase will support the success of the implementation phase.
he implementation phase includes educating the staff
bout the project and the initial introduction of the care
ools into practice. As mentioned, measuring the success of
ach of the activities and planning for additional activities is
ecessary to achieve best success.
After completing the educational plan, the oversight team
hould review the attendance and evaluations (if part of the
lan) and then decide if there is a need for additional
ducational presentations. This will complete a plan-do-
tudy-act cycle (PDSA) (17) related to the educational plan.
Plan  the educational plan
Do  execute the educational plan
Study  review the attendance and determine if 100% of
the involved staff have been reached
Act  develop plans to reach those who have not
attended an educational event
In all three Michigan AMI-GAP projects, a portion of
he nursing staff needed additional presentations, such as
hose on the midnight shifts, as well as clerical staff and
esource pool nurses. One hospital actually contacted the
esource pool manager and asked that they arrange for the
resentations. Another team prepared story boards that
ould rotate to units and reach the evening and night shifts.
ne team asked the central orientation department to
nclude the project and the clinical care tools as part of
entral orientation to reach new staff.
Physician staff that are important to inform about the
rocess but may be difficult to schedule may include resi-
ents rotating on the cardiology service, and non-
ardiologists who admit patients with AMI. In a large
eaching hospital, the chief resident sent out monthly
-mails and held orientation classes for those physicians
otating to the cardiology service. The physician champion
ecorded attendance at the monthly meetings to identify the
on-cardiologists that had not yet been reached. Several
eams had one-on-one follow-up by the physician champion
o physicians unable to attend the presentations.
Once the team has planned for implementation of the
ew tools, the start date represents a busy day for team
eaders because ideally they visit each unit on each shift,
etermine if the tools are being used, determine what the
arriers are, and make plans to immediately overcome the
arriers. Some of the barriers related to the start up were
npredictable, but are offered as lessons learned because if
ne can predict them then it may be possible to prevent
hem from happening. For example, one unit did not start
sing the new clinical care forms because the clerk thought
hat the priority should be to avoid waste and use all of the
ld forms before using the new forms. This was further
omplicated by the fact that the clerk had a “stash” of old
are forms hidden in the ceiling tiles so that she always had
ready supply! In a subsequent project, after hearing this
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November 15, 2005:1B–29B AMI ACC-GAP™ Case Studytory, a team decided that they would go to each unit,
emove the old forms, and replace them with the new forms.
nother team, unfortunately, forgot to check that the forms
ere back from the printer on time, and had to delay their
roject for three weeks.
Several major lessons were learned about the design and
rocess of using some of the care tools. Specific lessons to
he standard order set is to determine if they will be used in
he emergency department and, if so, then the emergency
epartment medical staff needs to be involved in the
lanning process. Some sites in GAP already had standing
rder sets and assumed that the order sets were being used
onsistently by all physicians and with all patients. In these
ituations the early treatment quality indicators influenced
y the standing orders did not improve. The data analysis
ndicated that the standing orders were not being used
onsistently. Thus, rather than assuming a high rate of use
f pre-existing order sets, an assessment should be com-
leted that includes current tool use rate and identifying
arriers to tool use.
Another barrier experienced by several hospitals was a
redetermined notion not to advocate for use of the order
et among physicians in training, thinking that standard
rders would interfere with their learning, and also by
roups of hospitalists who thought that they did not need
he “crutch” of standing orders. The care culture at each site
ill influence the ability to overcome these barriers. By far,
he most often sited barrier was physicians’ resistance to do
hat is perceived as “cookbook medicine.” Sometimes
hysician champions were able to overcome the resistance
ith one-on-one discussions and data feedback. When
ntroducing the standard order sets, it is important to
mphasize that the orders do not dictate the care; decisions
egarding patient care still need to be made on an individual
atient basis. The standard orders simply make those
ecisions easier to remember and to document. In the GAP
xperience, the sites with the highest standard order set use
ere the hospitals with electronic order entry as well as
hose sites that had very active physician champions and
mergency department involvement.
The standardized discharge documents in all but a few
ospitals were designed to be used by the nursing staff.
hose sites that required nurses to use two discharge forms,
he old general form and the new AMI specific form, had a
ow use of the discharge tools. There were a few sites that
esigned a form to be used by the physician alone or by the
hysician and the nursing staff. These sites had the lowest
ates of discharge tool use across all three projects. The sites
ith the highest discharge document rate were those sites
hat made standard use by nurses in every AMI patient a
lear expectation, monitored the use, and provided feed-
ack.
.1. Measures of a Successful Implementation Phase
efore moving on to the monitoring phase, the oversight
eam should pause and determine if they have successfully Tompleted the implementation phase. The following list
as common to most GAP participating hospitals, but each
versight team must develop their own checklist. Examples
nclude:
Educational plans completed
Attendance evaluated to determine those who were not
reached
Additional education sessions scheduled as needed
New care tools having been implemented
Staff concerns/issues discussed by team
Resistance and barriers identified
New strategies developed and implemented
.2. Potential Barriers in the Implementation Phase
fter determining the clinical tool use rate and identifying
arriers to tool use, the oversight team can develop strategies
o overcome the barriers. Several barriers have already been
iscussed; those that were most common in Michigan GAP
rojects are summarized in Table 5 with recommended
trategies to overcome them.
.0. MONITORING TOOL USE PHASE
his phase of the project is critical because it is the
easurement of the process change. Rather than just one
DSA cycle, it should include multiple PDSA cycles until a
igh rate of tool use is obtained. The PDSA cycles in the
onitoring phase are defined as:
Plan  use the care tools at a very high rate
Do  actually use the tools in practice, monitoring the
rates and getting feedback from the staff that helps
identify barriers and successes
Study  evaluate the rate of tool use, determine if the
rate has reached the target or if additional efforts are
required
Act  create new plans to overcome the barriers, and the
next PDSA cycle starts
As mentioned, these cycles are repeated until the tools are
eing used consistently at a high rate. This seems simple,
ut this phase can take as long as three to six months, based
n the cooperative nature and culture of the hospital staff
nd the oversight team’s ability to overcome the barriers.
eams that are struggling with meeting their goals will need
o be careful to avoid “aim drift” defined as deliberately
ecreasing or “drifting away” from a challenging aim (20). A
eam that is struggling with reaching high tool use may want
o refocus and perhaps consider continuing with a focus on
ust one or two of the tools, such as the discharge document
nd the standing orders.
.1. Measures of a Successful Monitoring Tool Use Phase
t is appropriate for the oversight team to pause at the end
f each PDSA cycle within the monitoring phase, and
eview a checklist of successful completion of this phase.
he checklist may seem obvious, but again needs to be
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AMI ACC-GAP™ Case Study November 15, 2005:1B–29Bndividually developed. Measures of successful monitoring
nclude:
Conduct monitoring
Œ Sample identified
Œ Patient records examined
Results analyzed
Rates and trends reviewed
Barriers and successes determined
New strategies to overcome barriers incorporated into
plan
Repetitive PDSA cycles are conducted
.2. Potential Barriers in the Monitoring Phase
s in the other phases, there are potential barriers that are
nique to the monitoring phases. Some of these are related
o tool use and were mentioned in section 3.7, but are
epeated here, because they are most commonly found in
his phase (Table 6).
.0. REMEASUREMENT PHASE
his phase should prove to be the reward for all of the hard
ork that has gone into the project. If a team has been
onitoring the tool use and successfully overcoming barriers
o that the tool use rate is high, it follows that the quality
able 5. Barriers of Implentation Phase
Potential Barriers in the Implementation Phase
. Physician resistance to standing orders 1. Ph
● Add
● Pro
. Staffing issues 2. In-
Shortage and turnover
Unreceptive to change
Unavailable for project education sessions
● Sho
● Em
and
● Too
● Use
. Confusion about clinical data 3. Pro
cal
. Staff perceive extra or additional documentation is
necessary for new forms
4. Fo
. Lack of buy-in by some staff 5. Pro
● Adm
● Mar
and
. ED not incorporated into GAP projects 6. ED
● Rec
influ
● May
. New forms not being used 7. Pro
Incorrect use
Failure to use new forms
● Obt
● Uni
● Eva
● Pro
● Foc
● Re-
. ACS patients identified as AMI patients late in
stay and standing orders are not started early on
8. So
sec
unlCS  acute coronary syndrome; AMI  acute myocardial infarction; ED  emergencyndicator rates are high as well. It is important in this phase
o follow plans for the sampling strategy and that data
ollection is completed in a timely manner. Occasional
uality checks to ensure that the sample is adequate and that
he data collection is completed correctly are warranted.
arly during the remeasurement phase, the team leaders
hould meet with the abstractors to determine if the medical
ecords are complete and that data abstraction is not being
ampered by incomplete records. When QI teams want to
easure care in a rapid-cycle project such as the GAP
roject, a common barrier is that the medical records are still
eing processed by coders, or physicians are taking their
ime before completing records, delaying closure of the
ecords and making them unavailable for abstraction. Both
f these barriers can be overcome, but it is important to
dentify early during the remeasurement phase, not after all
f the data has been collected.
Some unique lessons learned during the ACC AMI-
AP projects bear mentioning here. One site had a lower
han expected discharge tool use rate. This was confusing
ecause the records had been checked concurrently during
he admission, and there was a high rate of discharge tool
se. During review of the results, it was discovered that
ome of the medical records staff were disposing of the
ischarge form, thinking that they were a pilot form that
Strategies to Overcome Barriers
n champion role
ne-on-one and with personal feedback
ata feedback
e presentations
sentations using templates provided
e previous GAP project results and that GAP tools support complete
stent care
ger care when the staff are busy or new and/or pool staff are used.
r in-services in high profile places
information about inclusion and exclusion criteria, and how rates were
d
esigned with simple check boxes and replace (not add to) existing forms
ng project buy-in
ration to publicly support and identify the project as a priority
g department publicizes project with table tents, posters, newsletters,
-in
n ED physician champion and project leader to lend creditability and
lop ED GAP tools and process
ng form use
edback, input and support during planning and design phase
pion to monitor status and address unit-specific issues
availability of forms
n-services for unit clerk staff (who usually place forms on charts)
ease of documentation
ize with posters, examples, in-services, or one-to one feedback
spitals are using ACS standing orders and including a special page or
or AMI (ACS patients will usually receive aspirin and beta-blocker
ntraindicated)ysicia
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November 15, 2005:1B–29B AMI ACC-GAP™ Case Studyas not to be a permanent part of the records. Including the
edical records department in the planning phase can help
vercome this sort of barrier.
Engaging the medical records department in physician
eedback helped one site overcome the delayed closure of
ecords. Coders applied special “GAP notes to physicians”
o records that needed to be completed in a timely manner
or the rapid-cycle project.
During the remeasurement phase, it is important to track
MI patients that received PCI or cardiac surgery. In the
AP projects, it was observed that the patients that went
able 6. Barriers of Monitoring Phase
Potential Barriers in Monitoring Phase
. Difficulty identifying “patient monitoring sample”
promptly after discharge and/or while still
hospitalized
1. Mon
● Obtai
moni
● Secur
morn
● If the
ask fo
. Time constraints for monitoring tool use 2. Mon
● Enlis
easily
● Requ
. Samples are very small in low volume hospitals 3. Sam
● Trend
. Monitoring results are lower than expected. 4. Dete
● For e
certai
● Exam
all sta
● Follo
modif
. Physician resistance to standing orders 5. Phys
● Addr
● Provi
. Staffing issues 6. In-s
Shortage and turnover
Unreceptive to change
Unavailable for project education sessions
● Short
● Emph
consis
● Tools
● Use p
. Confusion about data 7. Prov
calcula
. Staff perceive extra or additional documentation
is necessary for new forms
8. Form
. Lack of buy-in by some staff 9. Prom
● Admi
● Mark
so on
0. New forms not being used 10. Pro
Incorrect use
Failure to use new forms
● Obtai
● Unit
● Evalu
● Provi
● Focus
● Re-en
1. ACS patients identified as AMI patients late in
stay and standing orders are not started early on
11. Som
sec
unl
SA  aspirin; CNS  clinical nurse specialist; other abbreviations as in Table 5.or PCI actually had high rates for the discharge indicators. oowever, those that received cardiac surgery had lower rates
or tool use and for evidence-based therapy for AMI at
ischarge. Collecting data at this level of detail allows for a
uch more focused action to improve the rates for a subset
f patents.
The remeasurement phase is not a time that the
eadership team can “sit back and take it easy.” There are
till barriers that need to be overcome, and early on to
nsure that the sample and data collection are complete
nd accurate. This is a good example of the potential use
f a subgroup to assume responsibility for a certain aspect
Strategies to Overcome the Barriers
g sample
st of elevated serum troponins from the laboratory and create a
sample from this list
MI list from admissions department, or review list of admits each
each week
staff who follow these patients such as a CNS or “rounding nurses”,
ir patient list to create a monitoring sample list
g strategies
help of staff already reviewing the records and provide a simple form to
tool use
at the unit clerks complete tool use forms as they work with the records
0% of the AMI patients
sed opportunity” cases rather than low denominator rates
e trends of tool use
le, are certain nursing units not using the discharge document? Are
sicians not using the standing orders?
e reasons for lack of use. Are the forms available on the chart? Were
serviced?
with those not using the forms. Addressing their concerns early, and
the process will lead to increased tool use.
champion to address
e-on-one and with personal feedback
ta feedback
presentations
ntations using templates provided
previous GAP project results and that GAP tools support complete and
care
er care when the staff are busy or new and/or pool staff are used.
in-services in high profile places
formation about inclusion and exclusion criteria, and how rates are
signed with simple check boxes and replace (not add to) existing forms
g project buy-in
tion to publicly support and identify the project as a priority
department publicizes project with table tents, posters, newsletters, and
g form use
dback, input, and support during planning and design phase
pion to monitor status and address unit-specific issues
ailability of forms
services for unit clerk staff (who usually place forms on charts)
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AMI ACC-GAP™ Case Study November 15, 2005:1B–29BOnce again, a PDSA cycle needs to be completed early in
he phase:
Plan  plans were created to measure post-intervention
Do  sample is created, data collection is completed
Study  determine if sample is correct, records are
available and complete, and data collection is completed
within time line and is accurate
Act  develop plans to overcome any barriers that have
surfaced during this phase, repeat PDSA cycle if
necessary
.1. Measures of a Successful Remeasurement Phase
t seems that as the completion of the project becomes
earer, the lists grow shorter, and the list of measures of a
uccessful remeasurement phase is indeed shorter than that
or previous phases. Project leaders should create a checklist
hat references the plan for remeasurement and minimally
onsists of:
GAP medical record process requirements met
Sample is correctly and completely created
Deficient record process altered to met project requirements
Data collection completed correctly
.2. Potential Barriers in the Remeasurement Phase
ome of these have been cited previously but are listed here
gain for emphasis (Table 7).
.0. RESULTS PHASE
his phase is meant not only to analyze the data that were
ollected, but also to determine successes and next steps, and
o celebrate. Often teams adopt an attitude of “we will plan
or it when we get there” and then overlook this important
hase. A strategy used by a previous GAP team was to
able 7. Barriers to Remeasurement Phase
Potential Barriers in
Remeasurement Phase
Strategies to
Overcome Barriers
. Normal medical record
processing takes longer
than the rapid cycle
demands of the AMI
GAP project
1. Define a special GAP medical
record process in collaboration
with medical records
department
. Physicians sometimes take
(the allowed) 60 days to
reconcile deficient charts
2. Outline a special effort to
decrease the normal time for
deficient AMI chart
completion
● Provide the “incomplete”
record list to the physician
champion for direct and timely
follow up with attending
physicians
● Make special announcements
about deficient records at the
medical staff meetings
● Consider special GAP notices
in physician mailboxespMI  acute myocardial infarction.nclude planning for this phase of the project in the
arketing plan.
Teams should collectively review the analysis and draw
onclusions about the status of the project relative to the
argets that were determined in the planning phase. Deci-
ions and recommendations about the new processes or
hanges implemented for the project could include:
Adopt the change;
Abandon the change; or
Alter and continue cycles of improvement;
Continue until target is reached.
Or perhaps the desired state has been achieved, in which
ase the team needs to make plans for sustaining improve-
ent and monitoring the tool use rates and indicator rates
o ensure that the improvements are sustained.
It is also important during this project phase to provide
eedback to all of the involved staff and departments. This
an be done with presentations at departmental meetings or
taff meetings. Some previous GAP participants have used
ewsletters, reports in paychecks, and poster story boards.
ertainly this should be a time to celebrate the successes! It
s also the time to prepare a final summary report to the
xecutive leadership team. The summary report can cite the
riginal aims of the project, comparative baseline and
emeasurement data, barriers and strategies that were used
o overcome the barriers, successes and lessons learned, and
conclusion statement with recommendations for next
teps.
.1. Measures of a Successful Results Phase
s previously mentioned, the lists are getting shorter in the
ater phases of project implementation, but this does not
inimize the importance of these activities. The PDSA
ycle and the measures of successful results phase are one
nd the same:
Plan  plans are made for analysis and report, and for
sharing results and giving feedback and acknowledge-
ments
Do  analysis completed and report prepared
Study  results reviewed by the team, determine if
project is successful and what the course of action will be,
celebrate and/or continue with PDSA cycles
Act  share results and next steps with staff, implement
plans for sustaining or continued improvement
.2. Potential Barriers in the Results Phase
arriers in this phase are related to planning or lack thereof.
ailure to design an analysis plan and report, or failure to
edicate resources for a celebration or determine a mecha-
ism to share the results with the staff is the usual source of
arriers in this phase. Strategies to overcome the barriers are
o develop the plans that are missing. Unfortunately, wait-
ng until this phase of the project to develop plans for this
hase may lead to delay because analytical staff may not be
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elebration.
.0. SUSTAINING THE GAIN
hen hospitals are successful and have reached their
argeted goals, it is important to develop a plan for sustain-
ng the gains they have made. Monitoring the quality
ndicators on a quarterly basis or once a year will indicate if
here is a slacking of performance. If the indicator rates do
tart to fall below a threshold predetermined by the team,
hen it is time to monitor tool use rates, identify trends of
se and barriers to use, and develop strategies to increase the
ool use to the previously successful state.
.0. SUMMARY
he ACC AMI-GAP projects were collaborative efforts of
ational and local leaders and hospital care teams. The
rojects showed that a systematic process of care that
ncluded the use of standardized order sets and discharge
ocuments improved the adherence and consistency of
vidence-based therapies such as aspirin, beta-blockers,
ngiotensin-converting enzyme inhibitors, statins, cholesterol-
owering medications, and smoking cessation and dietary
ounseling. Follow-up data analysis indicates that there is a
eduction in deaths in-hospital and at 30 days and 1 year
fter discharge when the GAP standardized tools were used.
sing the GAP methodology and approach and applying
AP hospitals lessons learned that are presented in this
upplement may help the hospital teams that are imple-
enting QI strategies to improve care of patients with
MI. Successful project implementation will produce a
roader use of standardized tools that will in turn lead to a
igher rate of application of evidence-based therapies.
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1.0. APPENDIX A: PROJECT PHASES GRID
ncluded here is the ACC AMI-GAP project phases
mplementation grid, designed as an outline of the narrative
ontained in this manual. It is not intended that the grid
ill provide all the information required for successful
roject implementation, but is a quick reference guide for
roject leaders.
AMI GAP Quality Improvement Project: Phases of Project Implementation
Project Phase Focus Output
Measurement of Successful
Implementation of Project Phase Potential Barriers
Planning Identify focus and secure
support and approval
Decision has been made to conduct AMI GAP
project and implement the ACC AMI tool
kit using standard orders, AMI discharge
document, critical pathway, patient
information forms, and measure project
success with quality indicator data collection
and tool use monitoring.
Resources:
● ACC AMI GAP articles (see reference list)
● ACC AMI GAP tool kit forms at
www.acc.org
Agreement to provide resources for the
project has been obtained from the
leadership of:
● Administration,
● Cardiology,
● Nursing,
● Emergency, and
● Quality improvement
● Failure to gain support from
leadership may lead to potential lack
of resources or recognition. Lack of
agreement/support may also
contribute to competing priorities.
Establish team Physician champion and project leader have
been identified and they convene a team
with representatives from all areas (those
who know and work with the process, or are
customers of the process). The team will
determine members’ contributions and
responsibilities for various aspects of project.
Sub teams are identified. Meeting frequency
and schedules will be agreed upon.
Resources and tools:
● Stakeholders list
● “High level” process flow chart
● Physician champion role description
● Project leader role and responsibilities
description
● Team membership list with physician
champion(s) and project leader(s)
identified.
● Team structure has been designed
● Members agree to roles and
responsibilities
● Team meeting frequency and
schedule has been determined
● Project leaders may feel overwhelmed
● Physician champion and/or project
leader may lack necessary QI skills
and comfort level to lead the project
● Project leaders may anticipate lack of
support
● Project leaders may have priorities
competing for available time and
energy for project oversight
Identify goals: answering
question #1: What are
we trying to accom-
plish? and question #2:
How will we know that
a change is an im-
provement?
Determine aim
Team members review baseline data report and
identify opportunities for improvement.
Baseline report should include data for all
quality indicators and if any of the tools are
already being used, determine the rate at
which they are being used. If individual units
(such as the Emergency Department, Cath
lab, critical care, and general care units) will
be developing an action plan, then each
should review a baseline report for the aspect
of care that they will be impacting or
focusing on. After identifying opportunities
for improvement, an aim statement should
be written. Each quality indicator and hohow
that indicator is calculated should be clearly
written and agreed upon. Some teams may
want to expand their definitions beyond the
current CMS or JCAHO core measures
quality indicators.
● Baseline data reviewed
● Opportunities for improvement are
prioritized
● A clear, focused statement of the
intended improvement is developed
● Quality indicator(s) statement is
written
● Quality indicator(s) calculation plan
is developed
● Well-defined aim statement is
written (if various units have
individual plan, each unit should have
an aim statement)
● Assuming the current status instead
of reviewing baseline data may
prevent team from identifying all
opportunities for improvement
● Failure to review the quality indicator
statements and calculations may lead
to failure to capture all the data and
information that the team determines
as important.
● Failure to write an aim statement
makes it difficult to motivate the staff
to work towards achieving a certain
target.
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Resources and tools:
Langley GJ, Nolan KM, Nolan TW, Norman
CL, Provost LP. The Improvement Guide. San
Francisco, CA: Jossey-Bass Publishers, 1996.
Improvement Method Available at:
www.QualityHealthcare.org. Institute for
Healthcare Improvement, Boston, MA.
● Data reports
● Internal, external
● Data variability
● Use data for discovery
● External triggers
● Guidelines
● QI tools; process flow, fishbone (cause and
effect), decision matrix
Develop action plan;
answering question #3:
What changes can we
make that will result in
improvement?
The team will generate a list of possible
improvements to address the selected
variances and then select specific actions.
Plans are also written for tool development
or modifications, tool approval and printing,
implementation of tools, educating the staff,
monitoring tool use, identifying barriers to
successful project implementation,
remeasurement, studying results and
reporting the status of the project. The plan
should include specific actions, who is
responsible and when the task should be
completed. The plan may also include
actions related to identifying the focus and
goals and team issues.
QI tools that may be used in developing plan:
● Reverse brainstorming
● Contingency diagram
● List of strategies
● Impact analysis
● Decision matrix
● Action plan
● PERT or GANTT chart
● Microsoft project
● Calendar
● CQI activity report
● A detailed plan for implementation
with:
● Tasks identified
● Responsible person(s) indicated,
● Time frames set and time line is
completed and shared
● Milestones identified (major events
that indicate progress)
● Evaluation criteria and checklist
If already using standardized order
form or AMI specific discharge
form, then:
● A change is planned after measuring
current rate of tool use and
identifying barriers
● Failure to write an action plan may
lead to oversight of important tasks,
or conflicting scheduling of aspects of
the project implementation.
● Medical forms committee process
may be longer than anticipated and
jeopardize start date of new tool
implementation
Continued on next page
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Project Phase Focus Output
Measurement of Successful
Implementation of Project Phase Potential Barriers
Determine methods to
monitor the rate of
tool use and strategy
to remeasure the
quality indicators
Plans for monitoring the tool use rates are
made and include a sampling criterion to
identify records to be examined,
determination of who will review the records
for tool use, and a strategy to identify
barriers to tool use. Team members then
create strategies to overcome the barriers.
And repeat the monitoring after
implementing the new strategies. A
remeasurement plan is developed to measure
improvement in the quality indicator rates.
Tools:
● Monitoring tools
● Data collection
● Information collection
● Reverse brain storming
● Clearly stated measurement plan for
the targeted improvement including:
● Data collection methods,
● Data analysis plan, and
● Responsible parties
● Plan to monitor tool use and identify
resistance and/or barriers
● Plan for developing strategies to
overcome barriers
● Failure to monitor the tool use rates
and identify barriers to tool use may
prohibit successful project
implementation.
● Inability to successfully and
completely implement a new process
may not sustain the new process.
Plan educational
“roll out”
The team should develop a mechanism (and
contents) to reach all those caring for
patients with AMI. This may include
sessions for physicians, nursing, and all
others who will be impacted by the new
tools and or processes of care.
A marketing plan may be developed to
promote the project’s importance and
increase visibility.
Tools:
● Standard educational package
● Storyboards
● Fliers
● Staff meeting schedules
● Content outline
● Educational plan and evaluation tool
written
● Educational sessions scheduled
● Key question to answer: Who wasn’t
in attendance?
● Plans to follow up with those not
in attendance are made
● Plans to follow up with those not
in attendance are made
● Failure to educate the staff about the
new tools/process and expectations
for use may lead to inconsistent tool
implementation.
Plan for reporting
project progress, data,
successes, barriers, and
lessons learned
Quality improvement projects should be
reported to an oversight or executive
committee and plans for the report and
reporting need to be developed.
Determine if project warrants IRB approval or
just reported to IRB as “for your
information.”
Resources and tools:
● Project timeline
● Project reporting form (phases measurements)
● Barriers and strategies listing
● Quality indicator progress report and data
forms
● Project reporting plans (to whom,
when, and format)
● Responsible parties and due dates are
identified
● Mechanism for gathering information
is determined
● Failure to report status and results
threatens recognition of the project
successes.
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Evaluation of planning
period
Complete a PDSA cycle: The team should
collectively review the written plan for
completion of details and identify issues
overlooked and then modify the plan as
needed.
Resources and tools:
● Planning checklist
● Written action plan
● Project timeline
● Outstanding issues identified and
written plan modify to include the
outstanding details.
● Team may overlook important details
if the plan is not reviewed for
completeness.
Implementation of
(plan) education
and implementation
of new tools
Educational plan imple-
mented and evaluated
Marketing strategies
completed
Complete PDSA cycle of education and
marketing roll out. Determine if plans were
instituted and also review attendance and
evaluations for those not in attendance or
issues that need to be addressed.
Resources and tools:
● Educational schedule
● Kickoff checklist
● Evaluation forms
● Attendance lists
● Education plan implementation and
marketing strategies evaluated
● Follow-up plans made to address
those not yet reached
● Not reviewing attendance may lead to
failure to reach all those impacted by
and depended upon to carry out the
project.
Test changes, new
process
Review implementation of the tools and
changes (PDSA cycle). Determine if all the
units start using the tools as planned and
identify successes and barriers to starting new
process.
● Implementation checklist
● Implementation unit report
● Tools have been implemented
● Change/improvement has been
implemented
● Each unit reports on the successes
and barriers to implementation
● Evaluate implementation
● Determine if changes to
implementation need to be made.
● Failure to determine early on if the
tools were indeed implemented may
lead to inconsistent use.
Monitoring
tool use
Monitor tool use,
identify barriers and
strategies to overcome
them
Measure the rate at which the tools are being
used on all units. Acknowledge success and
identify barriers to tool use. Develop
strategies to overcome barriers
(Repetitive PDSA cycles until target rate of
tool use is achieved and maintained.)
Resources and tools:
● Monitoring plan
● Monitoring tool use forms
● Reverse brainstorming
● Force field analysis
● Tool use rates reported
● Tool use driving and restraining
forces are identified (barriers, issues,
and successes).
● Failure to monitor the tool use rates
and identify barriers to tool use may
prohibit successful and consistent
project implementation.
● Failure to use the tools at a high rate
will diminish the quality indicator
rates.
● The improvements and new process
can not be sustained if the process is
not successfully and consistently
implemented.
Remeasurement Collect and analyze post
measurement data
Measurement plan is carried out and reviewed
to determine if the measurement was
completed as planned for. If not, then make
modifications and complete measurement
(PDSA cycle)
Resources and tools:
● Data collection tools
● Data reporting forms
● Graphs and charts
● Process variation
● Measurement data is collected as
described in the plan
● Data results are:
● Tabulated,
● Analyzed and
● Interpreted in relation to the aim
statements
● Lessons learned are listed
● Conclusion statement of success or
failure with explanation(s) completed
● Incomplete or inaccurate
measurement will lead to erroneous
conclusions.
Continued on next page
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Project Phase Focus Output
Measurement of Successful
Implementation of Project Phase Potential Barriers
Results New plans developed
based on results
Team should collectively review the analysis
and draw conclusions and recommendations
for modifications to new process.
● Decision/recommendation to:
● Adopt the change,
● Abandon the change, or
● Alter and continue cycles of
improvement
● Next PDSA cycle
Desired state achieved ● Data reports
● Tool use rates report
● List of barriers and successes
● Presentation
● Storyboarding
● Feedback to involved staff and
departments is completed
● Celebrate the success!
AMI  acute myocardial infarction; IRB  Institutional Review Board; PDSA  plan, do, study, act cycle; QI  quality improvement.
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November 15, 2005:1B–29B AMI ACC-GAP™ Case Study2.0. APPENDIX B: AMI-GAP PROJECT PLANNING FORMS (WRITTEN WORK PLAN TEMPLATE, TEAM MEMBER
IST, PLANNING CHECKLIST)
A
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□eam Member List
hysician champion
roject leader
hysicians (cardiology, family practice, internist, emergency)
urse mangers (critical care, telemetry units, general units,
emergency)
mergency department (physician and nursing)
Unit champions” of unit-based leaders
lerical staff
harmacy department
ollaborative quality improvement director
atheterization laboratory manager
ardiopulmonary
linical laboratory
edical recordsCC AMI-GAP Project Planning Checklist
Physician champion
Project leader
Team members and team structure
Meeting schedule
Forms are completed
Œ Standing orders
Œ Discharge document
Œ Critical pathway
Œ Patient information form
Œ Back from printer
QI selected and QI calculation plan determined
Data collection methodology determined
Plan and tool for monitoring designed
Baseline data collected and reviewed, aim statement
written
Tool implementation start date determined
Kickoff scheduled
Educational plans written and sessions scheduled
“Learning sessions” planned
Evaluation plan written
Reporting plans determined, report format designed□ Project plan written
MI GAP Project Work Plan
Topic
Assessment
Statement Plan/Strategies Timeline
Accountable
Person(s)
eam
Team members
Meetings (frequency, established, etc.)
Other
im statement
ools
Standing orders
Discharge document
Critical pathway
Patient information form
Pocket guide and card
mplementation plan
ducational plan
Grand rounds (date, established meeting?)
Inservices (packet will be distributed at the kickoff)
onitoring tool use
emeasurement
Identifying the universe
Medical records process
1T
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emplate AMI Orders
his standard order template is based on the ACC/AHA Guidelines for the Management of Patients With Acute
yocardial Infarction and is intended to capture key elements of care for an AMI patient as recommended in the guideline.
t is not intended to be as exhaustive and detailed as it would need to be in order to be used in practice. It is not intended
o be used “as is” but is intended to be modified for implementation at your institution. It is expected that you will need to
dd a considerable amount of detail in order to make this template into a fully functional standard order.tems presented in bold text in this standard order template are considered by the ACC to be elements of an AMI standard
rder because they are based on Class I recommendations from the ACC/AHA AMI Guideline. Removal of any of these
tems would result in a standard order that does not reflect the ACC/AHA recommended care for an AMI patient.
□ Admit to CCU □ Admit to Cardiac Stepdown Unit □ AMI Pathway
Diagnosis: □ ST Elevation or True Posterior (1 R, STD, 1T V1  V3) AMI □ Non-STEMI, T 2 AMI
Attending Physician: __________________________ Cardiologist: __________________________
□ Obtain old chart
□ VS per unit protocol; I & Os; daily weights
□ Pulse oximeter on admission, every ______ hrs, then p.r.n.
□ Nasal O2 at 2–4 l/min; maintain SaO2 90%
□ If SaO2 90%, Ventimask at ______ %
Establish □ 1 □ 2 IV lines ______ at ______ □ kvo □ ______ at ______ cc/h
Activity: □ Complete bed rest □ Bed rest with bedside commode □ Bed rest with BR privileges
□ Progress as tolerated
Diet: □ Low saturated fat/low cholesterol □ ADA ______ calories □ NAS
□ 2 g Na □ clear liquids □ NPO
MEDICATIONS
□ Aspirin ______ mg (160–325 mg) to be chewed now. □ aspirin contraindicated because: ____________________________________
□ Enteric Coated Aspirin Daily □ 325 mg □ 162 mg □ 81 mg □ aspirin contraindicated because: ___________________
□ clopidogrel 75 mg p.o. daily (for ASA allergy) loading dose of 300–375 mg for first dose prior to PCI
□ ticlopidine 500 mg loading plus 250 mg twice daily
□ IV Nitroglycerin bolus injection of 12.5–25 mcg and a pump-controlled infusion of 10–20 mcg/min, and increase the dosage by 5–10 mcg every
5–10 min titrate per protocol.
□ nitropaste ______ inch twice daily □ isordil
□ Heparin
□ For pts 70 kg, 60 units/kg bolus (maximum 4,000 units), then 12 units/kg/h (maximum infusion 1,000 units/h)—then as per nomogram
(target aPTT 50–70 s) for 48 h
OR
□ For pts 70 kg, 4,000 units bolus, then 1,000 units/h—then as per nomogram (target aPTT 50–70 s) for 48 h
□ subcutaneous heparin 7,500 units twice daily until ambulatory
□ Low Molecular Weight Heparin
□ enoxaparin 1 mg/kg subcutaneous every 12 h (alternative antithrombotic for non–STEMI)
□ dalteparin 120 units/kg of body weight, max 10,000 units subcutaneous every 12 h
□ IV GP IIb/IIIa
□ abciximab 0.25 mg/kg IV bolus; then continuous IV infusion of 0.125 mcg/kg/min (max 10 mcg/min) for 12 to 24 h
□ eptifibatide 180 mcg/kg IV bolus over 1–2 min; then 2.0 mcg/kg/min for 72 to 96 h
□ tirofiban 0.4 mcg/kg/min over 30 min; then 0.1 mcg/kg/min for 48 to 96 h
□ Beta-Blocker
□ metoprolol 5 mg IV over 2 min repeated every 5 min for a total initial dose of 15 mg
□ atenolol 5 mg IV repeated 5 min later
□ _____________________________________________________________________
□ Beta-blocker contraindicated because: ______________________________________
□ Morphine Sulfate 2–4 mg IV p.r.n. for chest pain if unrelieved by conventional therapy
□ Hospital Thrombolytic Protocol—administer within 30 min upon arrival of patient in ED
□ alteplase 15 mg IV bolus; 0.75 mg/kg (max 50 mg) over 30 min; 0.5 mg/kg (max 35 mg) over 60 min
□ reteplase double bolus 10 units each 30 min apart
□ streptokinase 1.5 million units in 30–60 min
□ tenecteplase 30 mg for pts  60 kg; 35 mg for pts 60 to 70 kg; 40 mg for pts 70 to 80 kg; 45 mg for pts 80 to 90 kg;
50 mg for pts  or  90 kg
□ Thrombolytic contraindicated because: _________________________________________________
□ Proceed immediately to Cath Lab for primary PCI—assure door to dilation time within 90 (30) min
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□ lisinopril 5 mg p.o. daily titrate upward p.r.n. for BP
□ captopril 6.25 mg p.o., then 12.5 mg 2 hrs later and 25 mg three times daily
□ enalapril 2.5 mg twice daily
□ ramipril 5–10 mg every day
□ ______________________
□ ACE inhibitor contraindicated because: ______________________________
□ Cholesterol-Lowering Drug
□ niacin
□ gemfibrozil
□ statin (preferred for isolated increase in LDL): ____________, ______ mg/p.o. with evening meal
□ Diuretic: ____________, ______ mg □ p.o. □ IV ____________
□ Compazine 5–10 mg IV every 4 h p.r.n. for nausea/vomiting
□ Stool softeners 100 mg p.o. twice daily
□ Antacids 30 cc p.m. daily
□ Acetaminophen 2 tabs every 4–6 h p.r.n.
STUDIES: (If not done in ED)
□ CBC with diff □ repeat in a.m.
□ BUN, creatinine, Lytes □ repeat in a.m.
□ Mg, Ca, Phos
□ Glucose
□ PT, INR, aPTT
□ Cardiac markers: □ troponin-T, troponin-I □ CK, CK-MB—as per hospital protocol
□ Lipid profile now (if not performed in past 4 months)
□ Fasting lipid profile in a.m.
□ ECG upon arrival to Unit and in a.m. □ Right-sided ECG
□ ECG with recurrent chest pain
□ Portable chest X-ray
□ ________________
□ ________________
□ ________________
INTERVENTIONS
□ Patient Education Form/Program
□ Smoking cessation instruction and counseling program—for all patients who smoke
□ Nutritional counseling
□ Secondary prevention counseling
□ Discharge contract re: understanding and complying with evidence-based therapy
□ Cardiac rehabilitation
□ Notify MD immediately for recurrent symptoms/ECG ischemia/CHF/hemodynamic decompensation/ventricular arrhythmias
□ Cardiac catherization: primary PCI, rescue for the failed thrombolysis, clinical conditions, cardiogenic shock/hemodynamic instability/CHF,
suspected mechanical complications, e.g. VSD, acute MR, malignant ventricular arrhythmia, ischemia in-hospital or pre-discharge ETT,
recurrent ischemia at rest with ECG changes (or repeated episodes without ECG changes), recurrent MI, high-risk non–STEMI patient
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Emergency Department
and First 24 Hours Next 24 Hours—Discharge Day At Discharge
onsults Cardiology consult in ED
ests 12 lead ECG within 10 min of
arrival in ED; cardiac serum
markers; admission blood work
Pre discharge ETT—for uncomplicated
patient, plan on 4–5 days
Cath1 patients with
significant ischemia (in-
hospital or pre-discharge
ETT)
Echo for CHF/shock/suspected
mechanical complications
Echo or MUGA prior to discharge if
no I V gram
spirin chewed in ED (325 mg) 160–325 mg daily 81–325 mg daily indefinitely
eperfusion for ST1 or
new LBBB 12 hrs of
symptom onset
Front loaded thrombolytics2 or
Primary PTCA
alteplase/reteplase, can be repeated for
recurrent occlusion
eparin IV in alteplase/reteplase or PTCA
treated patients; for large
anterior MI, AF, prior embolus,
LV thrombus; subcutaneous
heparin for streptokinase IV
heparin in LMWH
subcutaneous for non–ST-
elevated MI
48 h in alteplase/reteplase, or
emergency cath treated patients.
Consider subcutaneous heparin
minidose for all until ambulatory.
Coumadin
–For 3–6 mos if LV
thrombus seen or
thromboembolism;
–Chronically for AF
eta-blockers3 IV metoprolol (up to 15 mg in
3 divided doses) or IV Atenolol
(10 mg in 2 divided doses)
Calcium channel blockers if
beta-blockers ineffective or
contraindicated
Oral metoprolol 50–100 mg daily
Atenolol 50–100 mg QD, or other
beta blocker
Oral daily indefinitely
CE inhibitors Start within hours if BP 100,
no renal failure
Daily for up to 6 weeks Longer if Sx CHF or
LVEF 40%
Consider in all patients
P IIb/IIIa For primary PTCA or high risk,
non–ST-elevated MI
itroglycerin IV for 24–48 h, unless HR 50, Only for ongoing ischemia or
uncontrolled hypertension
Oral for residual ischemia
BP 90
tatins Indefinitely if LDL-C 100
mg/dl
ctivity Strict bedrest Start exercise Refer to rehab program near
ardiac rehab Bedrest/bedside commode as
tolerated
Hallway ambulation their home
iet Education on low fat diet Recommend low fat diet
low chol, low saturated
fat, no added salt as
tolerated
atient/family teaching ● Explain treatments
● Allay fears
● Sx recognition and reporting
● Pain scale
● Orient to unit and room; waiting
room; Family Group, Survival
Guide, Telecare, MI Patient
Hospital Stay Information and
AHA series
Prepare for all Discharge procedures,
explain treatments
Prepare for transfer off CICU; review
Sx recognition and reporting
Initiate as early as possible
Reinforce smoking cessation
Orient patient to: AHA
Active Partnership
workbook/video series
CHD section of workbook
Videos Taking Control and
Understanding CHD
Heart Attack Discharge
document
Videos Taking Control and
Understanding CHD
Heart Attack Discharge
document
ischarge planning Direct family to business office
Notify discharge planners
Home VCR?
1●
●
●
●
●
●
●
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Primary PTCA Contraindications Cautions
Rescue for the failed thrombolysis Known prior hemorrhagic CVA Persistent BP 80/110 mm Hg
Clinical conditions
Cardiogenic shock/hemodynamic instability/CHF
Suspected mechanical complications (e.g, VSD,
acute MR)
Recurrent symptomatic arrythmia
Ischemia in-hospital or pre-discharge ETT
Recurrent ischemia at res with ECG changes
(repeated episodes without ECG changes)
Recurrent MI
IC trauma
Active internal bleeding
Suspected aortic dissection
Prior cerebrovascular accident/intracerebral
pathology
Current use of anticoagulants in
therapeutic doses
Current use of anticoagulants in
therapeutic doses
Trauma or surgery within 2 weeks
Noncompressible vascular punctures
Recent (within 2–4 weeks) internal
bleeding
Pregnancy
Active peptic ulcer disease
History of chronic severe hypertension
2Thrombolytic Drug Dosing
Alteplase 15 mg bolus; 0.75 mg/kg over 30 min (max 50 mg); 0.5 mg/kg over 60 min (max 35 mg) anistreplase 30 in 5 min reteplase, double
bolus 10 units 30 min apart streptokinase, 1.5 million units infused over 60 min
3Relative Contraindications to Beta-Blockers
Heart rate  60 bpm PR interval  0.24 s Severe PVD
SBP  100 mm Hg Secondary or tertiary AV block IDDM
Signs of peripheral hypoperfusion Severe COPD
Severe LV failure Hx of asthma
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ear Patient:
ou are in the hospital because you may have had a heart attack. You will probably spend about 3–4 nights in the hospital.
his is a list of what you can expect to happen during your stay, but please remember that this is only a general guide. Your
are may vary from the guide because of your individual needs. Throughout your hospital stay always let the staff know if
ou have any chest discomfort, pain, or heaviness, shortness of breath, nausea, or weakness. Always ask any and all questions
ou have.ay 1:
You will probably be in the Cardiac Care Unit or in the Cardiology Unit
You will receive oxygen and medications to keep you comfortable and help your heart work.
You will be connected to a heart monitor and will have frequent blood pressure checks, blood tests, and ECGs. You may
have other tests scheduled, too.
You will have at least one IV (intravenous) line. We will tell you if you can eat or drink.
You may be on bed rest the first day—your doctor will determine your activities.
We will begin to teach about your condition, your medicines, and how you can lower the risk of having another heart
attack. If you smoke, we will counsel you about how to stop.
Visiting hours in the Cardiac Care Unit are:ay 2:
If you have been in the intensive care unit, you may be transferred to a general unit
Blood pressure checks, blood draws and tests will be less frequent
You may be able to increase your activity
Eating and drinking will probably increase
We will check your cholesterol levels and you may be started on a medication to lower your cholesterol. We will teach
you about the diet that is best for you
We will continue to teach you about your condition and how you can best take care of yourself
You may have an exercise test or heart catheterization to test your heart function.
Visiting hours in the cardiology unit are:ay 3 through discharge:
We will start getting you ready for discharge. We will teach you about:
● the medicines you will take at home,
● a diet that’s best for you,
● exercise, activity and rest, and returning to work,
● any follow up appointments and tests you will need,
● and a Cardiac Rehabilitation Program.
HI
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N
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know that I have had a heart attack and that I need to do the following:
. Take medicine. I understand that there are certain medications which may help to prevent a future heart attack and may help to extend my life.
Aspirin - ______ mg daily □ Yes □ Does not apply to me because:
ACE inhibitor - ________________ □ Yes □ Does not apply to me because:
A measure of how well my heart is pumping is
my ejection fraction. My ejection fraction 
______ %
Beta-blocker - ______________ □ Yes □ Does not apply to me because:
Cholesterol lowering - ______________ □ Yes □ Does not apply to me because:
My cholesterol values are as follows:
Total Cholesterol (TC)  ______ (goal: less than 200)
Low Density Cholesterol (LDL) - ______ (goal: less than 100)
High Density Cholesterol (HDL - “good” cholesterol)  ______ (goal: between 40–96)
Sublingual nitroglycerin tablets ______________ □ Yes □ Does not apply to me because:
. Quit smoking. I understand that smoking increases my chances of suffering from a future heart attack and that smoking causes other
llnesses which may shorten my life.
I smoke and have been counseled to stop. □ Yes □ I do not smoke
I will stop smoking by (date) ______________
I have been given medication to help me stop: ______________
Referral to smoking cessation classes:
Call ______________ at phone ______________
. Eat a low-fat diet. I understand that a diet that is low in cholesterol and fat may help to reduce my chances of suffering a future heart
attack.
I have received counseling about a low fat diet. □ Yes □ No □ Does not apply to me because
Nutrition Services Contact: Call ______________ at phone ______________ _________________________
. Exercise regularly.
have received activity instructions for the next 4–6 weeks, before I start cardiac rehabilitation. □ Yes □ No
have received a referral to an outpatient cardiac rehabilitation program. □ Yes □ No
ardiac rehabilitation contact: Call at phone: □ Does not apply because
____________________
. Learn about heart disease.
I have received cardiac education (AHA packet) during my hospitalization. □ Yes □ No
I know warning signs and symptoms of heart attack and action to take if they occur. □ Yes □ No
I have received instructions on my discharge medications. □ Yes □ No
. Follow-up with my physician.
I have a follow-up appointment made with my physician. □ Yes □ No □ Does not apply
The number to call if I have not received a follow-up appointment in 2 weeks is ________–_________________.
urse/Physician Signature/Date: Patient Signature/Date:
